NCT03682146

Brief Summary

This randomized trial was designed to address the lack of high-quality literature comparing robotic-assisted (RARP) and laparoscopic (LRP) radical prostatectomy (RP). Purpose: The LAP-01 trial compares outcomes between RARP and LRP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
782

participants targeted

Target at P75+ for not_applicable prostate-cancer

Timeline
Completed

Started Nov 2014

Longer than P75 for not_applicable prostate-cancer

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

May 15, 2015

Completed
3.4 years until next milestone

First Posted

Study publicly available on registry

September 24, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2021

Completed
Last Updated

November 30, 2023

Status Verified

September 1, 2020

Enrollment Period

6.5 years

First QC Date

May 15, 2015

Last Update Submit

November 29, 2023

Conditions

Keywords

DaVinciRobotic-AssistedProstatectomyLaparoscopyContinence

Outcome Measures

Primary Outcomes (1)

  • Early Continence

    The primary outcome is continence recovery at 3 months based on the patient's pad diary; RARP vs. LRP

    3 months after removal of the urinary catheter

Secondary Outcomes (13)

  • Continence

    1, 3, 6, 12 months postoperative

  • Continence

    1, 3, 6, 12 months postoperative

  • Erectile function

    1, 3, 6, 12 months postoperative

  • Health-related quality of life of patients

    1, 3, 6, 12 months postoperative

  • Prostate-specific quality of life of patients

    1, 3, 6, 12 months postoperative

  • +8 more secondary outcomes

Study Arms (2)

RARP

OTHER

robot-assisted laparoscopic prostatectomy

Procedure: Prostatectomy

LRP

OTHER

conventional laparoscopic radical prostatectomy

Procedure: Prostatectomy

Interventions

ProstatectomyPROCEDURE

Comparison of robotic-assisted and conventional laparoscopic radical prostatectomy

Also known as: robotic-assisted laparoscopic radical prostatectomy, conventional laparoscopic radical prostatectomy
LRPRARP

Eligibility Criteria

Age18 Years - 75 Years
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Histological verified prostate carcinoma (first diagnosis)
  • Indication for primary curative radical prostatectomy
  • Age ≤ 75 years
  • Patient agrees to randomisation
  • Patient is able to fill in the questionnaires on his own
  • Patient is willing to provide written informed consent

You may not qualify if:

  • Insufficient knowledge of German
  • Severe cognitive impairment
  • Obesity (BMI \> 35)
  • Current existing severe comorbidities (e.g. liver cirrhosis, second malignancy or relapse of every kind)
  • Tumor stage: T4
  • Previous malignancy (≤ 3 years before trial participation)
  • Neoadjuvant therapy (hormons) within the last 3 months before participation in the trial
  • Patient is immuno-compromised
  • History of intermittent urinary self-catheterization within the last year
  • Psychological disorders (dementia, chronic depression, psychosis)
  • Any of the following treatments ≤ 3 months before trial participation: surgery of the sigmoid colon, extended haemorrhoid resection, transurethral needle ablation of the prostate (TUNA), osteosynthesis of the pelvis, salvage prostatectomy
  • Patients with chronic urinary infection
  • Dialysis patients
  • Lacking willingness for data storage and handling in the frame of the trial protocol/aims

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Klinikum Dortmund

Dortmund, 44137, Germany

Location

Universitätsklinikum Düsseldorf

Düsseldorf, 40225, Germany

Location

University Hospital Heidelberg

Heidelberg, 69120, Germany

Location

University of Leipzig

Leipzig, 04103, Germany

Location

Related Publications (3)

  • Holze S, Kuntze AS, Mende M, Neuhaus P, Truss MC, Do HM, Dietel A, Franz T, Stolzenburg JU. Assessment of different continence definitions in the context of the randomized multicenter prospective LAP-01 trial-Does the best definition change over time? Eur J Med Res. 2024 Jan 18;29(1):58. doi: 10.1186/s40001-024-01662-5.

  • Holze S, Braunlich M, Mende M, Arthanareeswaran VK, Neuhaus P, Truss MC, Do HM, Dietel A, Franz T, Teber D, Heilsberg AK, Hohenfellner M, Rabenalt R, Albers P, Stolzenburg JU. Age-stratified outcomes after radical prostatectomy in a randomized setting (LAP-01): do younger patients have more to lose? World J Urol. 2022 May;40(5):1151-1158. doi: 10.1007/s00345-022-03945-0. Epub 2022 Feb 6.

  • Stolzenburg JU, Holze S, Neuhaus P, Kyriazis I, Do HM, Dietel A, Truss MC, Grzella CI, Teber D, Hohenfellner M, Rabenalt R, Albers P, Mende M. Robotic-assisted Versus Laparoscopic Surgery: Outcomes from the First Multicentre, Randomised, Patient-blinded Controlled Trial in Radical Prostatectomy (LAP-01). Eur Urol. 2021 Jun;79(6):750-759. doi: 10.1016/j.eururo.2021.01.030. Epub 2021 Feb 9.

MeSH Terms

Conditions

Prostatic Neoplasms

Interventions

Prostatectomy

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Urologic Surgical Procedures, MaleUrologic Surgical ProceduresUrogenital Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • Jens-Uwe Stolzenburg, Prof.

    Leipzig University, Department of Urology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients were blinded with respect to the surgical method until the end of the 3-month evaluation and extraction of the primary study outcome.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 15, 2015

First Posted

September 24, 2018

Study Start

November 1, 2014

Primary Completion

May 1, 2021

Study Completion

December 1, 2021

Last Updated

November 30, 2023

Record last verified: 2020-09

Locations